These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 12430933

  • 1. Pathogen inactivation of blood components: current status and introduction of an approach using riboflavin as a photosensitizer.
    Corbin F.
    Int J Hematol; 2002 Aug; 76 Suppl 2():253-7. PubMed ID: 12430933
    [Abstract] [Full Text] [Related]

  • 2. [Effects of use of riboflavin and ultraviolet light for pathogen inactivation on quality of platelet concentrates].
    Stanojković Z, Antić A, Stojanović M.
    Vojnosanit Pregl; 2011 Jun; 68(6):489-94. PubMed ID: 21818915
    [Abstract] [Full Text] [Related]

  • 3. Pathogen-reduction systems for blood components: the current position and future trends.
    Seghatchian J, de Sousa G.
    Transfus Apher Sci; 2006 Dec; 35(3):189-96. PubMed ID: 17110168
    [Abstract] [Full Text] [Related]

  • 4. Amotosalen: Allogeneic Cellular Immunotherapies system, INTERCEPT Plasma System, INTERCEPT Platelet System, S 59.
    BioDrugs; 2003 Dec; 17(1):66-8. PubMed ID: 12534321
    [Abstract] [Full Text] [Related]

  • 5. Towards the understanding of the UV light, riboflavin and additive solution contributions to the in vitro lesions observed in Mirasol®-treated platelets.
    Abonnenc M, Crettaz D, Sonego G, Escolar G, Tissot JD, Prudent M.
    Transfus Clin Biol; 2019 Nov; 26(4):209-216. PubMed ID: 31563447
    [Abstract] [Full Text] [Related]

  • 6. Pathogen reduction of blood components.
    Solheim BG.
    Transfus Apher Sci; 2008 Aug; 39(1):75-82. PubMed ID: 18602343
    [Abstract] [Full Text] [Related]

  • 7. The use of riboflavin for the inactivation of pathogens in blood products.
    Goodrich RP.
    Vox Sang; 2000 Aug; 78 Suppl 2():211-5. PubMed ID: 10938955
    [Abstract] [Full Text] [Related]

  • 8. Differential sensitivities of pathogens in red cell concentrates to Tri-P(4)-photoinactivation.
    Trannoy LL, Terpstra FG, de Korte D, Lagerberg JW, Verhoeven AJ, Brand A, van Engelenburg FA.
    Vox Sang; 2006 Aug; 91(2):111-8. PubMed ID: 16907871
    [Abstract] [Full Text] [Related]

  • 9. Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment.
    Keil SD, Bengrine A, Bowen R, Marschner S, Hovenga N, Rouse L, Gilmour D, Duverlie G, Goodrich RP.
    Transfusion; 2015 Jul; 55(7):1736-44. PubMed ID: 25731607
    [Abstract] [Full Text] [Related]

  • 10. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light.
    Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP.
    Transfusion; 2004 Jun; 44(6):877-85. PubMed ID: 15157255
    [Abstract] [Full Text] [Related]

  • 11. Pathogen inactivation treatment of plasma and platelet concentrates and their predicted functionality in massive transfusion protocols.
    Arbaeen AF, Schubert P, Serrano K, Carter CJ, Culibrk B, Devine DV.
    Transfusion; 2017 May; 57(5):1208-1217. PubMed ID: 28236302
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.